Clinical experience in using long-acting human insulin Glargine 300 U/ml in the practice of an endocrinologist

Abstract

Diabetes mellitus (DM) is a severe chronic disease which prevalence continues to increase steadily worldwide. According to the latest data, the number of patients with DV worldwide has more than doubled over the past 10 years and by the end of 2015 reached 415 million people. The government expenditure on the treatment of patients who have developed diabetes complications significantly outweigh the expenditure on patients without complications. Timely diagnosis, efficient and safe modern therapy, including insulin therapy with the use of next generation insulin, make it possible to optimize control over the economic burden of DM.

Keywords

• diabetes mellitus
• pharmacotherapy
• insulin therapy
• glargine 300 u/ml.